45
CollPlant Biotechnologies closes $9.25M raise in Israel-based biotech
Company raise · Closed · Offering $9.2M · Sold $9.2M · Rehovot, Ireland · filed 2026-10-22
Placement agent engaged
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Oren Fahimipoor | Vice President, Operations |
| Bowman Bagley | Vice President, Commercial North America |
| Yehiel Tal | Chief Executive Officer and Interim Chairman of the Board of Directors |
| Abraham Havron | Director |
| Alisa Lask | Director |
| Elan Penn | Director |
| Hugh Evans | Director |
| Bar Abelis | Vice President, Legal |
| Philippe Bensimon | Vice President, Regulatory Affairs and Quality Assurance |
| Jasmine Seror | Vice President, Product Development |
| Joseph Zarzewsky | Director |
| Eran Rotem | Deputy Chief Executive Officer and Chief Financial Officer |
Signed by Eran Rotem, Deputy Chief Executive Officer and Chief Financial Officer.
Placement agents / sales compensation: H.C. Wainwright & Co., LLC
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.